Happy New Year to all PEF Followers
I want to thank you all for following Psychiatry Education Forum and giving me the encouragement to continue this educational journey. In 2020: we published two online courses, 11 journal club discussions, posted >260 chapters in our course and crossed 6000 followers on social media. This journey isn’t over yet. We have more educational updates planned for you all in 2021 🙂
This is our last post for 2020: this post will summarize the top 5 viewed psychiatry articles discussed on the psychiatry education forum’s journal club:
-TOP 5 PSYCHIATRY ARTICLES-
DISCUSSED ON PSYCHIATRY EDUCATION FORUM IN 2020
(1) PSYCHOTROPICS ADVERSE EVENTS MANAGEMENT:
Adjunctive Metformin for Antipsychotic-Induced Dyslipidemia
Adjunctive metformin was significantly superior to placebo with regards to low-density lipoprotein cholesterol (LDL-C), total cholesterol, triglyceride, and high-density lipoprotein cholesterol.
(2) GERIATRIC PSYCHIATRY:
Association of Benzodiazepines & Z-Drugs with Subsequent Dementia
- This large cohort study did not reveal associations between the use of benzodiazepines or Z-drugs and subsequent dementia, even when exposures were cumulated or divided into long- and short-acting drugs.
(3) PTSD VS COMPLEX PTSD:
International Trauma Questionnaire (ITQ) for PTSD Assessment
(4) MAJOR DEPRESSION DISORDER:
ISNPR Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder
- The subcommittee of the International Society for Nutritional Psychiatry Research organized an expert panel and conducted a literature review and a Delphi process to develop a consensus-based practice guideline for clinical use of n-3 PUFAs in MDD. The guideline focuses on 5 thematic areas: general concepts, acute treatment strategy, depression recurrence monitoring and prevention, use in special populations, and potential safety issues.
(5) SCHIZOPHRENIA & RELATED PSYCHOTIC DISORDERS:
Comparing 32 Oral Antipsychotics for Acute Multi-Episode Schizophrenia Treatment
Article: Lancet. 2019;394(10202):939-951.
- There are some efficacy differences between antipsychotics, but most of them are gradual rather than discrete. Differences in side-effects are more marked. These findings will aid clinicians in balancing risks versus benefits of those drugs available in their countries.
(Video courtesy Dr. Lena Palaniyappan, in support of continuous professional learning activities provided by Psychiatry Education Forum)
INTERESTED IN LEARNING MORE?
JOIN OUR COURSE & GET ACCESS TO COMPLETE JOURNAL CLUB DISCUSSIONS:
PHYSICIAN’S GUIDE FOR CLINICAL PSYCHIATRY COURSE
- Total chapters: 260+ Chapters.
- Chapters and Sections are frequently updated.
- Peer2Peer ChatRoom: Makes learning process more active via engagement among subscribers.
- Journal Club: we will post most recently published psychiatry articles relevant to your daily clinical practice.
- Coffee Club: contain short discussions with clinical experts in the field of psychiatry
- Goal: is to have all important clinically relevant topics in one course.
- Annual Subscription of $65/year: for continued access to course on an annual basis.